Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
Deloitte
McKinsey
Fish and Richardson
Federal Trade Commission
McKesson
QuintilesIMS
Chubb
Citi

Generated: October 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: nevirapine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
17782AII10/26/2004HETERO LABS LTDNEVIRAPINE
17851AII11/16/2004AUROBINDO PHARMA LTDNEVIRAPINE ANHYDROUS USP
17905AII12/17/2004CIPLA LTDNEVIRAPINE USP
17915AII12/16/2004MYLAN LABORATORIES LTDNEVIRAPINE USP (ANHYDROUS)
18401AII5/22/2005AUROBINDO PHARMA LTDNEVIRAPINE HEMIHYDRATE UPS
18576AII7/30/2005AUROBINDO PHARMA LTDNEVIRAPINE ANHYDROUS USP
19368AII4/14/2006MYLAN LABORATORIES LTDNEVIRAPINE HEMIHYDRATE USP
19379III10/10/2005MATRIX LABORATORIES LTDNEVIRAPINE USP, NON-STERILE BULK FORM
19712AII8/11/2006ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDNEVIRAPINE USP
19753AII4/3/2008CIPLA LTDNEVIRAPINE HEMIHYDRATE USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
Citi
Farmers Insurance
Boehringer Ingelheim
Accenture
Cerilliant
Merck
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot